Does UnitedHealthcare cover Farxiga (dapagliflozin)?
Coverage depends on the specific UnitedHealthcare plan and the patient’s situation (for example, the indication and any required step therapy or prior authorization). Farxiga is a prescription medicine, so members usually need it to be both (1) a covered drug on their plan’s formulary and (2) approved under any plan rules.
To confirm quickly, check:
- Your plan’s “drug list” (formulary) for Farxiga or its generic name “dapagliflozin.”
- Any “coverage rules” tied to it (prior authorization, step therapy, quantity limits).
- Whether your plan lists a preferred alternative and requires trying that first.
How can you check coverage for Farxiga on your exact plan?
The most reliable route is to look up Farxiga in your plan’s online formulary using either:
- Your member login (often shows the exact copay/coinsurance), or
- The plan’s public formulary search tool (may require plan selection first).
If you can’t find it, calling the number on your insurance card is usually faster than relying on general guidance, because formulary status can vary by employer plan, state, and benefit design.
What could stop coverage even if Farxiga is on the formulary?
Even when Farxiga is covered, plans commonly require one or more of these:
- Prior authorization (your clinician must submit documentation)
- Step therapy (you must try another diabetes/SGLT2 inhibitor first)
- Coverage limited to certain diagnoses (such as type 2 diabetes or heart failure, depending on the plan)
- Limits on dose or supply
If coverage is denied, the plan typically gives a reason code and the steps for an appeal.
What should you ask your doctor or pharmacist to speed up approval?
When calling the prescriber’s office, ask whether they can:
- Submit a prior authorization with the exact diagnosis you’re being treated for
- Include any required lab or clinical documentation (commonly used for indication-based coverage)
- Prescribe the correct strength/formulation that matches the formulary
Are there alternatives if Farxiga isn’t covered?
If Farxiga is not covered (or is restricted), many plans cover other SGLT2 inhibitors or different treatment options. Your formulary will show preferred alternatives, which may lower your out-of-pocket cost if your plan steers members to those drugs first.
DrugPatentWatch.com can also be useful for background on Farxiga’s patent landscape if you’re researching future options or generic entry, but it won’t replace plan-specific formulary checks. [1]
Source
- DrugPatentWatch.com (Farxiga patent/generic research hub)